ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,264Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 102

$623K Total Retail Price of All Prescriptions

Rank: 21 out of 102

492 Patients Receiving at Least One Drug in Part D
85% Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in South Dakota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 492 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LISINOPRIL 471 371 74 1 5
FUROSEMIDE 447 432 77 2 4
LEVOTHYROXINE SODIUM 423 340 61 3 1
SIMVASTATIN 397 361 75 4 3
TRAMADOL HCL 345 270 73 5 15
AMLODIPINE BESYLATE 333 319 54 6 6
OMEPRAZOLE 333 299 62 6 2
CITALOPRAM HBR 316 288 50 8 17
POTASSIUM CHLORIDE 251 211 43 9 9
METFORMIN HCL 245 219 46 10 14
ATENOLOL 233 222 34 11 16
METOPROLOL TARTRATE 222 217* 41 12 12
LOSARTAN POTASSIUM 221 216* 42 13 10
CLOPIDOGREL 208 203* 29 14 20
WARFARIN SODIUM 200 195* 33 15 7
NAMENDA 181 181 13 16 34
METOPROLOL SUCCINATE 179 161 33 17 8
TAMSULOSIN HCL 173 154 29 18 21
CARVEDILOL 168 163* 28 19 22
ALLOPURINOL 164 150 26 20 25
HYDROCODONE-ACETAMINOPHEN 161 86 30 S3 21 13
ATORVASTATIN CALCIUM 147 115 32 22 11
DONEPEZIL HCL 146 146 23 23 27
HYDROCHLOROTHIAZIDE 140 120 28 24 18
ALPRAZOLAM 137 121 26 B 25 45
FENOFIBRATE* 130 73 21 26 71
PREDNISONE 126 104 64 27 28
GABAPENTIN 119 97 17 28 19
POLYETHYLENE GLYCOL 3350 112 84 14 29 33
SPIRONOLACTONE 106 106 15 30 32
ROPINIROLE HCL 101 96* 14 31 67
FINASTERIDE 99 99 16 32 70
FAMOTIDINE* 93 <11 <11 33 83
LORAZEPAM 93 68 22 B 33 29
DIGOX 93 93 11 33 57
DIGOXIN 92 87* 18 36 42
SERTRALINE HCL 89 62 17 37 23
ALENDRONATE SODIUM 89 89 17 37 24
TRIAMTERENE-HCTZ 88 74 11 39 40
GLIPIZIDE 86 81* 14 40 66
FENTANYL 84 <11 <11 S2 41 36
GEMFIBROZIL 80 58 12 42 75
SPIRIVA 80 67 16 42 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 71* 20 44 52
CEPHALEXIN 74 55 54 45 80
ARICEPT 73 <11 <11 46 203
ISOSORBIDE MONONITRATE ER 73 62 11 46 39
LANTUS 70 65* 11 48 44
NAPROXEN 67 45 26 49 154
KLOR-CON M20 66 <11 <11 50 53
ZOLPIDEM TARTRATE 65 30 16 51 31
DIOVAN 65 <11 <11 51 41
ADVAIR DISKUS 65 49 12 51 47
IPRATROPIUM-ALBUTEROL 63 <11 <11 54 106
LOSARTAN-HYDROCHLOROTHIAZIDE 61 61 11 55 38
CRESTOR 61 <11 <11 55 26
CIPROFLOXACIN HCL 61 56* 45 55 74
NEXIUM 60 <11 <11 58 46
LANTUS SOLOSTAR 59 <11 <11 59 76
PANTOPRAZOLE SODIUM 59 <11 <11 59 73
VENLAFAXINE HCL ER 59 <11 <11 59 102
AMLODIPINE BESYLATE-BENAZEPRIL 55 <11 <11 62 142
TRAZODONE HCL 54 <11 <11 63 49
PRAVASTATIN SODIUM 53 41 12 64 30
CLOZAPINE 52 <11 <11 A 65 153
AMITRIPTYLINE HCL 52 <11 <11 R 65 62
MONTELUKAST SODIUM 51 <11 <11 67 61
JANTOVEN 51 <11 <11 67 100
PHENYTOIN SODIUM EXTENDED 50 <11 <11 69 142
OXYBUTYNIN CHLORIDE ER 50 50 12 69 82
EVISTA 50 <11 <11 69 118
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.